DexCare Stock
Operations, Productivity And CommunicationLooking to sell DexCare stock or options?
DexCare has developed an access optimization platform that intelligently manages health system capacity and digital demand across various business segments. The platform enables patients to receive appropriate care settings, helping healthcare organizations attract new patients, boost revenue, enhance satisfaction, and achieve significant cost savings. As a result, patients access the care they need more quickly, easily, and effectively.
Mass General Brigham Ventures, SpringRock Ventures, Kaiser Permanente Ventures, Define Ventures, ICONIQ Growth, Transformation Capital, Frist Cressey Ventures, Providence Ventures.
Collective explained in 2 minutes
Learn how Collective's solutions enable you to manage your risk and maximize your wealth
Our available services for this company
Management Team
Board Members
DexCare’s stock FAQs
DexCare is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize DexCare stock. Depending on DexCare’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange DexCare stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of DexCare stock in two ways. First, DexCare employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your DexCare stock. Note that all transactions in DexCare shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
DexCare stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for DexCare stock. Typically, shares of private companies like DexCare are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Jun 2023, DexCare is reported to have closed an equity financing in which the investors valued the company at $430M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of DexCare shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because DexCare is not currently publicly traded, it does not have a ticker symbol.
DexCare has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though DexCare is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on DexCare shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.
